Sequential treatment failures in response to BRAF/MEK and immune checkpoint inhibitors mediated by MAP2K2 and B2M mutations in melanoma
Richmond, Craig S., Vallatharasu, Yazhini, Deviley, Jake A., Vos, Cullen R., Parsons, Benjamin M., Kenny, Paraic A.Language:
english
Journal:
Experimental and Molecular Pathology
DOI:
10.1016/j.yexmp.2019.104260
Date:
May, 2019
File:
PDF, 8.50 MB
english, 2019